In vivo assessment of antidiabetic and antioxidative activity of natural phytochemical isolated from fruit-pulp of Eugenia jambolana in streptozotocin-induced diabetic rats

Redox Report

Volumn 22, Issue 6, 2017, Pages 301-307

  Tanwar, Reenu Singh ^a   Sharma, Suman Bala ^a   Prabhu, Krishna Madhava ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

antidiabetic activity; antioxidative activity; diabetes mellitus; Eugenia jambolana; streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; FIIC; GLUCOSE; LIPID; UNCLASSIFIED DRUG; PLANT EXTRACT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; FRUIT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; INFRARED SPECTROSCOPY; ION EXCHANGE CHROMATOGRAPHY; LIPID BLOOD LEVEL; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYZYGIUM CUMINI; ULTRAVIOLET RADIATION; ANIMAL; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; SYZYGIUM; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FRUIT; HYPOGLYCEMIC AGENTS; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; STREPTOZOCIN; SYZYGIUM;

EID: 84988622302     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1080/13510002.2016.1229892     Document Type: Article

References (36)

1. Scheen JA. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s. achievements and future development. Drugs. 1997;54:355–368. doi: 10.2165/00003495-199754030-00001
2. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Hardman JG, Limbard LE, Goodman, Gilman’s AG, editors. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill Companies Inc.; 1996. p. 1679–1714.
3. Jayawardena MH, De Alwis NM, Hettigoda V, et al. A double blind randomized placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetes. J Ethnopharmacol. 2005;97:215–218. doi: 10.1016/j.jep.2004.10.026
4. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002;81:81–100. doi: 10.1016/S0378-8741(02)00059-4
5. Achrekar S, Kaklij GS, Pote MS, et al. Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: mechanism of action. In vivo. 1991;5:133–148.
6. Vikrant V, Grover JK, Tandon N, et al. Treatment with extracts of Momordica charentia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J Ethnopharmacol. 2001;76:139–143. doi: 10.1016/S0378-8741(01)00218-5
7. Sharma SB, Nasir A, Prabhu KM, et al. Hypoglycemic and hypolipidemic effect of ethanolic extracts of seeds of Eugenia jambolana in alloxan induced diabetic model of rabbits. J Ethnopharmacol. 2003;85:201–206. doi: 10.1016/S0378-8741(02)00366-5
8. Ravi K, Sivagnanam K, Subramanian S. Antidiabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats. J Med food. 2004;7:187–191. doi: 10.1089/1096620041224067
9. Sridhar SB, Sheetal UD, Pai MR, et al. Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Braz J Med Biol Res. 2005;38:463–468. doi: 10.1590/S0100-879X2005000300018
10. Sharma B, Balomajumder C, Roy P. Hypoglycemic and hypolipidemic effects of flavanoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol. 2008;46:2376–2383. doi: 10.1016/j.fct.2008.03.020
11. Sharma SB, Rajpoot R, Nasir A, et al. Ameliorative effect of active principle isolated from seeds of Eugenia jambolana on carbohydrate metabolism in experimental diabetes. Evid Based Complement Alternat Med. 2009; doi:10.1093/ecam/nep233.
12. Sharma SB, Nasir A, Prabhu KM, et al. Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J Ethnopharmacol. 2006;104:367–373. doi: 10.1016/j.jep.2005.10.033
13. Tanwar RS, Sharma SB, Singh UR, et al. Attenuation of renal dysfunction by herbal compound isolated from Eugenia jambolana in streptozotocin induced diabetic rats. Indian J Biochem Biophys. 2010;47:83–89.
14. Tanwar RS, Sharma SB, Singh UR, et al. Antiatherosclerotic potential of active principle isolated from Eugenia jambolana in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med. 2011; Article ID 127641. doi:10.1155/2011/127641.
15. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110. doi: 10.1016/0304-3959(83)90201-4
16. Sorg DC, Buckner B. A simple method of obtaining venous blood from small laboratory animals. Proc Soc Exp Biol Med. 1964;115:1131–1132. doi: 10.3181/00379727-115-29134
17. Barham D, Trinder P. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst. 1972;97:142–145. doi: 10.1039/an9729700142
18. Goldstein DE, Little RR, Weidmeyer HM, et al. Glycated haemoglobin methodologies and clinical applications. Clin Chem. 1986;32:64–70.
19. Brandstrup N, Kirk JE, Bruni C. 1957. The hexokinase and phosphor glucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol. 1957;12:166–171. doi: 10.1093/geronj/12.2.166
20. Racker E. Spectrophotometric measurement of hexokinase and phosphohexokinase activity. J Biol Chem. 1947;167:843–854.
21. Koide H, Oda T. Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clinica Chimica Acta. 1959;4:554–561. doi: 10.1016/0009-8981(59)90165-2
22. Racker E, Schroeder EA. The reductive pentose phosphate cycle. II. Specific C-1 phosphatases for fructose-1,6-diphosphate and sedoheptulose-1,7-diphosphate. Arch Biochem Biophys. 1958;74:326–344. doi: 10.1016/0003-9861(58)90004-3
23. Fossati P, Prencipe L. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077–2080.
24. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–475.
25. Burstein M, Scholnick HR, Morfin R. Rapid method for isolation of lipoprotein from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583–595.
26. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43. doi: 10.1016/0009-8981(78)90081-5
27. Beutler E, Duron O, Kellin BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–888.
28. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:469–474. doi: 10.1111/j.1432-1033.1974.tb03714.x
29. Nandi A, Chatterjee B. Assay of superoxide dismutase activity in animal tissues. J Biosci. 1988;13:305–315. doi: 10.1007/BF02712155
30. Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–394. doi: 10.1016/0003-2697(72)90132-7
31. Chang AT, Noble J. Estimation of HbA1c like glycosylated proteins in kidneys of streptozotocin diabetes and controlled rats. Diabetes. 1979;28:408–415.
32. Horwitz DL, Starr JI, Mako ME, et al. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 1975;55:1278–1283. doi: 10.1172/JCI108047
33. Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86:965–971. doi: 10.1210/jcem.86.3.7304
34. Saravanan R, Pari L. Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement Altern Med. 2005;5:14–21. doi: 10.1186/1472-6882-5-14
35. Santhakumari P, Prakasam A, Pugalendi KV. Modulation of oxidative stress parameters by treatment with piper beetle leaf in streptozotocin-induced diabetic rats. Indian J Pharmacol. 2003;35:373–378.
36. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405–412. doi: 10.2337/diab.40.4.405